首页> 外国专利> THERAPEUTIC AND PROPHYLACTIC AGENT FOR GLIOMA, BRAIN TUMOR MALIGNANCY MARKER, BRAIN TUMOR PROGNOSTIC MARKER, METHOD FOR DETERMINING MALIGNANCY AND PROGNOSIS OF BRAIN TUMOR AND ANTIBODY INHIBITING TUMOR PROLIFERATION

THERAPEUTIC AND PROPHYLACTIC AGENT FOR GLIOMA, BRAIN TUMOR MALIGNANCY MARKER, BRAIN TUMOR PROGNOSTIC MARKER, METHOD FOR DETERMINING MALIGNANCY AND PROGNOSIS OF BRAIN TUMOR AND ANTIBODY INHIBITING TUMOR PROLIFERATION

机译:胶质瘤的治疗和预防剂,脑肿瘤的恶性肿瘤标志物,脑肿瘤的恶性肿瘤标志物,脑肿瘤的恶性程度和预后的判定方法以及抑制肿瘤增殖的抗体。

摘要

The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for a glioma, a brain tumor malignancy marker, a brain tumor prognostic marker, a method for determining the malignancy of a brain tumor, and a method for determining the prognosis of a brain tumor patient. According to the present invention, provided are: a therapeutic and prophylactic agent for a glioma, said agent containing an HVEM inhibitor as an active ingredient; a brain tumor malignancy marker and a brain tumor prognostic marker, each marker comprising an HVEM protein or an HVEM gene; and a method for determining the malignancy of a brain tumor and a method for determining the prognosis of a brain tumor patient, each method comprising a step for measuring the HVEM expression level in a biological sample collected from a subject.
机译:本发明的目的是提供用于神经胶质瘤的新型治疗剂或预防剂,脑肿瘤恶性标记,脑肿瘤预后标记,确定脑肿瘤恶性的方法以及确定脑胶质瘤的预后的方法。脑肿瘤患者。根据本发明,提供了:用于神经胶质瘤的治疗和预防剂,所述药物包含HVEM抑制剂作为活性成分;和脑肿瘤恶性标志物和脑肿瘤预后标志物,每个标志物包含HVEM蛋白或HVEM基因;以及确定脑肿瘤的恶性的方法和确定脑肿瘤患者的预后的方法,每种方法包括测量从受试者收集的生物样品中的HVEM表达水平的步骤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号